← Oncology Approval Tracker

FDA DECISION ·

Clolar

clofarabine · Genzyme / Sanofi

Traditional approvalTraditional conversionAcute lymphoblastic leukemia
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Patients ages one through 21 with relapsed or refractory ALL after at least two prior regimens.

LAMPGEN ANALYSIS

Why it matters

The decision converts the previous accelerated approval for this pediatric and young adult population.

What research teams should watch

Retain the historical age and prior-regimen criteria when comparing the original and converted approvals.

PRIMARY RECORDS

Sources